Compare this to the side effect profile of pharmaceutical GLP-1 medications , where nausea affects 40 to 50 percent of users, vomiting occurs in 20 to 30 percent, and constipation is reported by a significant proportion of people throughout treatment
This is not a lazy plan because you do not care
Jump to: Who should never take weight-loss injections | Conditions that need extra caution | Medications that interact | Pregnancy, breastfeeding and age | If you are scheduled for surgery | When to stop and seek help | Questions to ask your GP | Frequently asked questions | Take home message You shouldnt take weight-loss injections like Wegovy (semaglutide) or Mounjaro (tirzepatide) if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN-2), type 1 diabetes, or have had a serious allergic reaction to a GLP-1 medication
At a stable dose, food noise and appetite can partly return as weight loss approaches a plateau
After a couple hours I just started throwing everything up, because nothing was going the other way
Geoff Geredien (00:24:39): I don't know if I've seen a geographic distribution as much as there are certainly some industry trends in terms of maybe companies with knowledge workers versus other manufacturing or construction related industries
